|
|
Volumn 11, Issue 5, 2007, Pages 649-656
|
|
Sorafenib: a promising new targeted therapy for renal cell carcinoma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENZENESULFONIC ACID DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIDINE DERIVATIVE;
SORAFENIB;
CANCER STAGING;
CASE REPORT;
CHEMICALLY INDUCED DISORDER;
DIARRHEA;
DRUG DELIVERY SYSTEM;
DRUG ERUPTION;
DRUG INTERACTION;
DRUG MONITORING;
FATIGUE;
HUMAN;
HYPERTENSION;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
MALE;
MIDDLE AGED;
NURSE ATTITUDE;
NURSING ASSESSMENT;
ONCOLOGY NURSING;
ORAL DRUG ADMINISTRATION;
ORGANIZATION AND MANAGEMENT;
PATIENT COMPLIANCE;
PROGNOSIS;
PSYCHOLOGICAL ASPECT;
REVIEW;
RISK FACTOR;
SOCIAL SUPPORT;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CARCINOMA, RENAL CELL;
DIARRHEA;
DRUG DELIVERY SYSTEMS;
DRUG ERUPTIONS;
DRUG INTERACTIONS;
DRUG MONITORING;
FATIGUE;
HUMANS;
HYPERTENSION;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
NURSE'S ROLE;
NURSING ASSESSMENT;
ONCOLOGIC NURSING;
PATIENT COMPLIANCE;
PROGNOSIS;
PROTEIN KINASE INHIBITORS;
PYRIDINES;
RISK FACTORS;
SOCIAL SUPPORT;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 38449101219
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/07.CJON.649-656 Document Type: Review |
|
Times cited : (26)
|
|
References (44)
|
